Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan

Among patients with heart failure and reduced ejection fraction (left ventricular (LV) ejection fraction ≤40%), sacubitril/valsartan (S/V) treatment is associated with improved health status and reverse cardiac remodeling. Data regarding racial and ethnic differences in response to S/V are lacking....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Heart Fail
Main Authors: Ibrahim, Nasrien E., Piña, Ileana L., Camacho, Alexander, Bapat, Devavrat, Felker, G. Michael, Maisel, Alan S., Butler, Javed, Prescott, Margaret F., Abbas, Cheryl A., Solomon, Scott D., Januzzi, James L.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7769180/
https://ncbi.nlm.nih.gov/pubmed/33016100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.007829
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados